Compare Regeneron Pharmaceuticals Inc (REGN) vs United Parcel Service Inc (UPS) Price & Performance

Regeneron Pharmaceuticals (REGN) trades at $739.57, up 0.12% on the day, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company maintains robust profitability with a net income margin of 27.86%. A major $8 billion expansion of the immunology alliance with Sanofi, announced October 1, 2026, provides significant future revenue potential and strategic momentum.

The outlook is positive, supported by strong earnings, a lucrative partnership, and a consensus analyst price target of $846. Key risks include competitive pressures in key drug markets and reliance on successful clinical trial outcomes. The stock presents a compelling opportunity for growth investors, though volatility may persist near-term.

UPS trades at $94.11, up 1.07% with bearish technical signals but strong fundamentals including a 17.15 P/E ratio and 29.66% ROE. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the UPS Secure Commerce platform launch and TikTok Shop partnership, while analysts maintain a $118.67 consensus price target despite near-term margin pressures.

UPS presents a value opportunity with attractive valuation metrics and consistent earnings beats, though declining revenue and competitive pressures from Amazon pose challenges. The 7% dividend yield provides income support, but investors should monitor domestic package volume trends and margin sustainability given recent analyst downgrades and bearish technical indicators.